Subtype

Male Reproductive System Neoplasm

Non-malignant1,533 active trials27 approved drugs58 evidence items

NCIt: C3054

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (287)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 101–125 of 287 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.
Tynisha S Rafael, Alberto Gil-Jimenez, Laura Elst et al. · Cancer Immunol Res · Sep 17, 2026 · PMID 42754263 · candidate dictionary pubmed
Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.
Amit D Raval, Sheila Mpima, Vicky Casey et al. · Oncologist · Sep 17, 2026 · PMID 42757692 · candidate dictionary pubmed
CRISPR/Cas9 screening revealed BIRC6-AS1/BIRC6 mediates abiraterone resistance via NHEJ pathway-dependent A20 degradation in prostate cancer.
Lan Li, Xue-Ni An, Yong-Tong Ruan et al. · Oncogene · Sep 17, 2026 · PMID 42754663 · candidate dictionary pubmed
PGC1α-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progression.
Maider Fagoaga-Eugui, Natalia Martin-Martin, Amaia Zabala-Letona et al. · Cell Death Differ · Sep 17, 2026 · PMID 42754649 · candidate dictionary pubmed
Excessive Bladder Filling at Simulation Correlates with Longer Treatment Times, More Interruptions, and Inferior Patient Experiences During Prostate Cancer Radiotherapy.
Thomas P Howard, Daniel G Barkyoumb, Jillian Connolly et al. · Pract Radiat Oncol · Sep 17, 2026 · PMID 42754036 · candidate dictionary pubmed
Detection of Clinically-Significant Prostate Cancer on Systematic Biopsy in Patients with a PI-RADS 3-5 Lesion on MRI: Results from a Large Institutional Series.
Cameron J Britton, Keavash Assani, Randie E White et al. · Urology · Sep 17, 2026 · PMID 42753979 · candidate

dictionary

pubmed

Radium-223 alters the levels of soluble immune regulators in the plasma of patients with metastatic castrate-resistant prostate cancer.

Lunj S, Mistry H, Christodoulou T et al. · Cancer Treat Res Commun · Sep 17, 2026 · PMID 42753580 · candidate dictionary pubmed

Immunohistochemical investigation of the stem cell landscape of canine prostate cancer.

Michelle M Story, Carlos E Fonseca-Alves, Renee Laufer-Amorim et al. · J Comp Pathol · Sep 17, 2026 · PMID 42753338 · candidate dictionary pubmed

Proteomic profiling reveals that DPP4 overexpression increases cell adhesion, inhibits cell migration, and restores androgen sensitivity in prostate cancer.

José María Mora-Rodríguez, Belén G Sánchez, Alicia Bort et al. · Biosci Rep · Sep 16, 2026 · PMID 42634954 · candidate dictionary pubmed

Castration-resistant prostate cancer as an adaptive tumor ecosystem: coupling tumor evolution with microenvironmental reprogramming.

Siliang Wang, Xinyi Xu, Minghuang Xu et al. · Cancer Metastasis Rev · Sep 16, 2026 · PMID 42747576 · candidate dictionary pubmed

Limited incremental prognostic value of pretreatment MRI and 18F-piflufolastat PET intensity metrics in grade group ≥ 3 prostate cancer.

Nuttaphon Aleenajitpong, Rory L Cochran, Sarah Mercaldo et al. · Abdom Radiol (NY) · Sep 16, 2026 · PMID 42747479 · candidate dictionary pubmed

ATP-Dependent Chromatin Remodelers in Prostate Cancer Progression and Therapeutic Resistance.

Lillian M Torres, Clayton Yates, Charlotte L Bevan et al. · Endocrinology · Sep 16, 2026 · PMID 42747431 · candidate dictionary pubmed

Global management of drug-drug interaction in patients with prostate cancer: international survey by Meet-URO group and ONCOassist.

Anna Amela Valsecchi, Michele Maffezzoli, Maria Concetta Cursano et al. · Oncologist · Sep 16, 2026 · PMID 42747311 · candidate dictionary pubmed

Survival benchmarking of talazoparib plus enzalutamide in homologous recombination repair-deficient metastatic castration-resistant prostate cancer: a reconstructed individual patient data analysis.

Hiroki Tanaka, Hiroshi Fukushima, Shigehiro Tsukahara et al. · Jpn J Clin Oncol · Sep 16, 2026 · PMID 42747074 · candidate dictionary pubmed

Prognostic value of baseline PSMA PET/CT for survival in synchronous metastatic hormone-sensitive prostate cancer: towards redefining low- and high-volume disease.

Fleur Kleiburg, Linda Heijmen, Annemieke Witteveen et al. · Eur Radiol · Sep 16, 2026 · PMID 42749930 · candidate dictionary pubmed

Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro).

Sigrid V Carlsson, Roderick van den Bergh · Eur Urol Focus · Sep 16, 2026 · PMID 42749606 · candidate dictionary pubmed

Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019.

Mattia Longoni, Giorgio Gandaglia, Francesco Montorsi · Eur Urol · Sep 16, 2026 · PMID 42749562 · candidate dictionary pubmed

Re: Derya Tilki, Roderick C.N.van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.014.

Michael Froehner · Eur Urol · Sep 16, 2026 · PMID 42749561 · candidate dictionary pubmed

[Molecular Diagnostics and Personalized Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC)].

Marie Semmler, Jozefina Casuscelli, Stefanie Zschäbitz et al. · Aktuelle Urol · Sep 16, 2026 · PMID 42748971 · candidate dictionary pubmed

Natural product-derived compounds modulating STAT3 signaling in prostate cancer: Mechanistic insights and therapeutic potential.

Yikun Feng, Danming Liu, Chen Gu et al. · Biomed Pharmacother · Sep 16, 2026 · PMID 42748829 · candidate dictionary pubmed

Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer.

Songqi Zhang, Muqing Li, Mingyu Liu et al. · Proc Natl Acad Sci U S A · Sep 15, 2026 · PMID 42715072 · candidate dictionary pubmed

Structure-optimized 4-trifluoromethylquinoline derivatives: Dual enhancement of SGK1 inhibition and anti-prostate cancer efficacy.

Yafang Zhou, Sha Cheng, Cheng Li et al. · Bioorg Chem · Sep 15, 2026 · PMID 42242016 · candidate dictionary pubmed

Electrochemical biosensor-based strategies for sensitive detection of prostate cancer biomarkers.

Atanu Saha, Kalicharan Sharma · Clin Chim Acta · Sep 15, 2026 · PMID 42235733 · candidate dictionary pubmed

Urological Content Accuracy as an Unmeasured Dimension in Generative AI Chatbot Communication About Sexual Health After Prostate Cancer.

Bilgi Isler, Ahmet Murat Bayraktar · JMIR Cancer · Sep 15, 2026 · PMID 42743405 · candidate dictionary pubmed

Authors' Reply: Urological Content Accuracy as an Unmeasured Dimension in Generative AI Chatbot Communication About Sexual Health After Prostate Cancer.

Mats Christiansen, Henrik Eriksson, Lisbeth Fagerström · JMIR Cancer · Sep 15, 2026 · PMID 42743403 · candidate dictionary pubmed